Melatonin

Hormone supplement with an EU-authorised claim that it contributes to the reduction of time taken to fall asleep; the effect is a few minutes.

Evidence
Strong evidenceGRADE certainty: High
Typical dose
1 mg close to bedtime
Time to effect
Small effect on time to fall asleep
Safety
Has documented cautions

Evidence ratings summarise published research on Melatonin in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Melatonin

Interactions

Taking any medication?

Check Melatonin against it.

Why

Endogenous hormone supplement. EU-authorised claim: "Melatonin contributes to the reduction of time taken to fall asleep." Meta-analyses find a small effect, roughly 4 to 6 minutes, and one 2022 meta-analysis found no significant benefit in adults with chronic insomnia. The German insomnia guideline advises against long-term use.

How it works

Endogenous pineal hormone that binds MT1/MT2 receptors in the suprachiasmatic nucleus; shifts circadian phase and shortens sleep-onset latency.

Expected onset · Small effect on time to fall asleep, roughly 4 to 6 minutes in meta-analyses

How to take

Dosage

1 mg close to bedtime (EFSA-authorised dose for sleep-onset latency). For jet lag, 0.5–5 mg has been studied; higher doses are not more effective.

Timing

30–60 min before intended sleep time

Safety

May cause morning grogginess; driving soon after a dose is best avoided. In the UK melatonin is a prescription-only medicine; it is not for children without medical advice. Avoid in pregnancy and breastfeeding (insufficient data). Fluvoxamine can raise melatonin levels many-fold. Caution in epilepsy and autoimmune disease, and with anticoagulants or immunosuppressants.
Loading interactions…

Evidence

At a glance

EU authorised claim: "Melatonin contributes to the reduction of time taken to fall asleep." Brzezinski 2005 Sleep Med Rev meta-analysis (17 studies, n=284) found sleep onset about 4 minutes shorter than with placebo; Maruani 2023 found 5 to 6 minutes for prolonged-release melatonin in insomnia disorder, whereas Choi 2022 found no significant benefit in adults with chronic insomnia.

GRADE certainty: High — EU authorised claim

Questions people ask

Does Melatonin work?

EU authorised claim: "Melatonin contributes to the reduction of time taken to fall asleep." Brzezinski 2005 Sleep Med Rev meta-analysis (17 studies, n=284) found sleep onset about 4 minutes shorter than with placebo; Maruani 2023 found 5 to 6 minutes for prolonged-release melatonin in insomnia disorder, whereas Choi 2022 found no significant benefit in adults with chronic insomnia. Certainty of the evidence: High, EU authorised claim.

How is Melatonin taken?

1 mg close to bedtime (EFSA-authorised dose for sleep-onset latency). For jet lag, 0.5–5 mg has been studied; higher doses are not more effective. Timing: 30–60 min before intended sleep time. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

May cause morning grogginess; driving soon after a dose is best avoided. In the UK melatonin is a prescription-only medicine; it is not for children without medical advice. Avoid in pregnancy and breastfeeding (insufficient data). Fluvoxamine can raise melatonin levels many-fold. Caution in epilepsy and autoimmune disease, and with anticoagulants or immunosuppressants. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: EU authorised health claim: “Melatonin contributes to the reduction of time taken to fall asleep.”; EU authorised health claim: “Melatonin contributes to the alleviation of subjective feelings of jet lag.”; Brzezinski A et al., Effects of exogenous melatonin on sleep: a meta-analysis, Sleep Med Rev 2005; Maruani J et al., Efficacy of melatonin and ramelteon for the acute and long-term management of insomnia disorder in adults: A systematic review and meta-analysis, J Sleep Res 2023; Choi K et al., Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses, Sleep Med Rev 2022; Wyatt JK et al., Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent, Sleep 2006; Garfinkel D et al., Improvement of sleep quality in elderly people by controlled-release melatonin, Lancet 1995; AWMF guideline (2025): S3-Leitlinie Insomnie bei Erwachsenen, Update 2025 (AWMF 063-003).

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.